Other Species / Isoforms
  NUF2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K21-ub
IVIHIRNkILTGADG
0 2
NUF2 (human) IVIHIRNkILTGADG K21-ub
NUF2 (mouse) LVVHIRNKLLTGADG K21
K29-ub
ILTGADGkNLTkNDL
0 5
NUF2 (human) ILTGADGkNLTkNDL K29-ub
NUF2 (mouse) LLTGADGKNLSKSDF K29
K33-ub
ADGkNLTkNDLyPNP
0 1
NUF2 (human) ADGkNLTkNDLyPNP K33-ub
NUF2 (mouse) ADGKNLSKSDFLPNP K33
Y37-p
NLTkNDLyPNPKPEV
0 6
NUF2 (human) NLTkNDLyPNPKPEV Y37-p
NUF2 (mouse) NLSKSDFLPNPKSDV L37
K113-ub
TADILCPkAkRTSRF
0 2
NUF2 (human) TADILCPkAkRTSRF K113-ub
NUF2 (mouse) IVDILNPRTNRTSRF R113
K115-ub
DILCPkAkRTSRFLS
0 1
NUF2 (human) DILCPkAkRTSRFLS K115-ub
NUF2 (mouse) DILNPRTNRTSRFLS N115
K151-ub
QYKSSADkMQQLNAA
0 2
NUF2 (human) QYKSSADkMQQLNAA K151-ub
NUF2 (mouse) QNKSSMVRMQQLSNV R151
K165-ub
AHQEALMkLERLDsV
0 2
NUF2 (human) AHQEALMkLERLDsV K165-ub
NUF2 (mouse) VHQEALMKLEKLNTV K165
S171-p
MkLERLDsVPVEEQE
0 6
NUF2 (human) MkLERLDsVPVEEQE S171-p
NUF2 (mouse) MKLEKLNTVPAEERE T171
K181-ub
VEEQEEFkQLsDGIQ
0 1
NUF2 (human) VEEQEEFkQLsDGIQ K181-ub
NUF2 (mouse) AEEREEFKQFMDDIQ K181
S184-p
QEEFkQLsDGIQELQ
0 1
NUF2 (human) QEEFkQLsDGIQELQ S184-p
NUF2 (mouse) REEFKQFMDDIQELQ M184
K201-ub
LNQDFHQkTIVLQEG
0 2
NUF2 (human) LNQDFHQkTIVLQEG K201-ub
NUF2 (mouse) LNEEFRQKTTLLQEE K201
N209
TIVLQEGNsQkKSNI
0 2
NUF2 (human) TIVLQEGNsQkKSNI N209
NUF2 (mouse) TTLLQEEyAKMKSDI Y209-p
S210-p
IVLQEGNsQkKSNIS
0 1
NUF2 (human) IVLQEGNsQkKSNIS S210-p
NUF2 (mouse) TLLQEEyAKMKSDIS A210
K212-ub
LQEGNsQkKSNISEK
0 1
NUF2 (human) LQEGNsQkKSNISEK K212-ub
NUF2 (mouse) LQEEyAKMKSDISEK M212
K234-ub
KLSVVSLkEIQEsLk
0 1
NUF2 (human) KLSVVSLkEIQEsLk K234-ub
NUF2 (mouse) KLSLVSLKEVEDNLK K234
S239-p
SLkEIQEsLktkIVD
0 1
NUF2 (human) SLkEIQEsLktkIVD S239-p
NUF2 (mouse) SLKEVEDNLKSKIVD N239
K241-ub
kEIQEsLktkIVDsP
0 1
NUF2 (human) kEIQEsLktkIVDsP K241-ub
NUF2 (mouse) KEVEDNLKSKIVDsP K241
T242-p
EIQEsLktkIVDsPE
0 1
NUF2 (human) EIQEsLktkIVDsPE T242-p
NUF2 (mouse) EVEDNLKSKIVDsPE S242
K243-ub
IQEsLktkIVDsPEk
0 1
NUF2 (human) IQEsLktkIVDsPEk K243-ub
NUF2 (mouse) VEDNLKSKIVDsPEK K243
S247-p
LktkIVDsPEkLKNY
Upstream
0 38
Treatment
  • EGF
NUF2 (human) LktkIVDsPEkLKNY S247-p
NUF2 (mouse) LKSKIVDsPEKLKNY S247-p
K250-ub
kIVDsPEkLKNYKEK
0 2
NUF2 (human) kIVDsPEkLKNYKEK K250-ub
NUF2 (mouse) KIVDsPEKLKNYKDK K250
T261-p
YKEKMKDtVQKLKNA
0 1
NUF2 (human) YKEKMKDtVQKLKNA T261-p
NUF2 (mouse) YKDKMKGTVQKLRSA T261
K299-ub
EVQLYQKkIQDLSDN
0 3
NUF2 (human) EVQLYQKkIQDLSDN K299-ub
NUF2 (mouse) EVQLYQKKSQDLADN K299
K309-ub
DLSDNREkLASILkE
0 2
NUF2 (human) DLSDNREkLASILkE K309-ub
NUF2 (mouse) DLADNREKLSSLLKE K309
K315-ub
EkLASILkESLNLED
0 3
NUF2 (human) EkLASILkESLNLED K315-ub
NUF2 (mouse) EKLSSLLKESLNLED K315
S329-p
DQIESDEsELkKLkT
0 1
NUF2 (human) DQIESDEsELkKLkT S329-p
NUF2 (mouse) DQIESDSSELKKLKT S329
K332-ub
ESDEsELkKLkTEEN
0 2
NUF2 (human) ESDEsELkKLkTEEN K332-ub
NUF2 (mouse) ESDSSELKKLKTEEN K332
K335-ub
EsELkKLkTEENSFk
0 1
NUF2 (human) EsELkKLkTEENSFk K335-ub
NUF2 (mouse) SSELKKLKTEENSLI K335
K342-ub
kTEENSFkRLMIVkK
0 1
NUF2 (human) kTEENSFkRLMIVkK K342-ub
NUF2 (mouse) KTEENSLIRMTTVKK I342
K348-ac
FkRLMIVkKEKLATA
0 1
NUF2 (human) FkRLMIVkKEKLATA K348-ac
NUF2 (mouse) LIRMTTVKKEKLATA K348
K358-ub
KLATAQFkINKKHED
0 1
NUF2 (human) KLATAQFkINKKHED K358-ub
NUF2 (mouse) KLATARFKINKKQED K358
K367-ub
NKKHEDVkQYKRTVI
0 1
NUF2 (human) NKKHEDVkQYKRTVI K367-ub
NUF2 (mouse) NKKQEDVKHYKQAMI K367
K379-ub
TVIEDCNkVQEkRGA
0 2
NUF2 (human) TVIEDCNkVQEkRGA K379-ub
NUF2 (mouse) AMIEDCNKVQEKRDA K379
K383-ub
DCNkVQEkRGAVyER
0 1
NUF2 (human) DCNkVQEkRGAVyER K383-ub
NUF2 (mouse) DCNKVQEKRDAVCEQ K383
Y388-p
QEkRGAVyERVTTIN
0 1
NUF2 (human) QEkRGAVyERVTTIN Y388-p
NUF2 (mouse) QEKRDAVCEQVTTVN C388
K400-ub
TINQEIQkIkLGIQQ
0 1
NUF2 (human) TINQEIQkIkLGIQQ K400-ub
NUF2 (mouse) TVNQEIHKIKSAIQQ K400
K402-ub
NQEIQkIkLGIQQLk
0 2
NUF2 (human) NQEIQkIkLGIQQLk K402-ub
NUF2 (mouse) NQEIHKIKSAIQQLR K402
K409-ub
kLGIQQLkDAAEREK
0 2
NUF2 (human) kLGIQQLkDAAEREK K409-ub
NUF2 (mouse) KSAIQQLRDTKKREI R409
K418-ub
AAEREKLkSQEIFLN
0 2
NUF2 (human) AAEREKLkSQEIFLN K418-ub
NUF2 (mouse) TKKREILKSQEIFVN K418
K427-ub
QEIFLNLkTALEkYH
0 2
NUF2 (human) QEIFLNLkTALEkYH K427-ub
NUF2 (mouse) QEIFVNLKSALEKYH K427
K432-ub
NLkTALEkYHDGIEk
0 2
NUF2 (human) NLkTALEkYHDGIEk K432-ub
NUF2 (mouse) NLKSALEKYHEGIEK K432
K439-ub
kYHDGIEkAAEDSYA
0 2
NUF2 (human) kYHDGIEkAAEDSYA K439-ub
NUF2 (mouse) KYHEGIEKVAEERSA K439
K447-ub
AAEDSYAkIDEkTAE
0 1
NUF2 (human) AAEDSYAkIDEkTAE K447-ub
NUF2 (mouse) VAEERSAKLEEKTAE K447
K451-ub
SYAkIDEkTAELKRK
0 1
NUF2 (human) SYAkIDEkTAELKRK K451-ub
NUF2 (mouse) RSAKLEEKTAELKKR K451
T464-p
RKMFKMSt_______
Upstream
0 1
Treatment
  • ischemia
NUF2 (human) RKMFKMSt_______ T464-p
NUF2 (mouse) KKRMVRMV_______ V463